CD44 and ovarian carcinoma: The results of an analysis of EMT markers and cell morphology showed that epithelial ovarian cancer (EOC)-derived EVs promoted the EMT independent of TGFβ signalling by transferring CD44+ EVs to human peritoneal mesothelial cells (HPMCs) [87].